1. 3346 BeyPro1: a Phase II single-arm study for the treatment after recurrence of advanced melanoma patients harboring the V600BRAF mutation and pretreated with Vemurafenib, with the association of Vemurafenib plus Fotemustine. (September 2015) Authors: Queirolo, P.; Spagnolo, F.; Picasso, V.; Simeone, E.; Grimaldi, A.M.; Curvietto, M.; Giorello, L.; Fontana, V.; Merlo, D.F.; Ascierto, P.A.; Bruzzi, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1392: The abscopal effect:efficacy of radiotherapy in patients on progression after ipilimumab 3 mg/kg. (April 2016) Authors: Grimaldi, A.M.; Ascierto, P.A.; Simeone, E.; Giannarelli, D.; Falivene, S.; Borzillo, V.; Giugliano, F.; Sandomenico, F.; Petrillo, A.; Curvietto, M.; Esposito, A.; Paone, M.; Palla, M.; Palmieri, G.; Caraco, C.; Ciliberto, G.; Mozzillo, N.; Muto, P. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expression of CD73 on MDSCs and CD8+/PD-1+ cells as new possible biomarkers for advanced melanoma patients treated with nivolumab. (March 2018) Authors: Fratangelo, F.; Morello, S.; Madonna, G.; Capone, M.; Mallardo, D.; Falcone, R.; Grimaldi, A.M.; Simeone, E.; Vanella, V.; Giannarelli, D.; Sorrentino, C.; Pinto, A.; Ascierto, P.A. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immuno-related adverse events from check-point inhibitors during immune-therapy for cancer. Imaging findings. (March 2018) Authors: Sandomenico, F.; De rosa, G.; Pizza, S.; Catalano, O.; Setola, S.; Simeone, E.; Festino, L.; Grimaldi, A.; Vanella, V.; Petrillo, A.; Ascierto, P. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma. Issue 1 (December 2016) Authors: Divitiis, C.; Arx, C.; Grimaldi, A.; Cicala, D.; Tatangelo, F.; Arcella, A.; Romano, G.; Simeone, E.; Iaffaioli, R.; Ascierto, P.; Tafuto, S. Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0741: Ipilimumab and stereotactic radiosurgery with cyberknife in melanoma brain metastases. (May 2017) Authors: Borzillo, V.; Di Franco, R.; Falivene, S.; Martino, A.; Ravo, V.; Totaro, G.; Giugliano, F.M.; Ascierto, P.A.; Grimaldi, A.M.; Festino, L.; Simeone, E.; Vanella, V.; Cammarota, F.; Giannarelli, D.; Muto, P. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Validation and in vivo assessment of an innovative satellite-based solar UV dosimeter for a mobile app dedicated to skin health. Issue 9 (2nd August 2016) Authors: Morelli, M.; Masini, A.; Simeone, E.; Khazova, M. Journal: Photochemical & photobiological sciences Issue: Volume 15:Issue 9(2016:Sep.) Page Start: 1170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Validation of a satellite-based solar UV-A radiation dosimeter for mobile healthcare applications. (April 2021) Authors: Morelli, M.; Michelozzi, B.; Simeone, E.; Khazova, M. Journal: Journal of atmospheric and solar-terrestrial physics Issue: Volume 215(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗